Maynard Um
-
-
-
-
-
-
-
Regenxbio Inc. (RGNX) PT Lowered to $32 at H.C. Wainwright
-
-
-
-
-
-
-
Baird on Regenxbio Inc. (RGNX): 'Incrementally negative on program update'
-
-
-
-
-
-
-
Regenxbio Inc. (RGNX) PT Raised to $20 at Leerink Partners
-
-
-
-
-
-
-
Goldman Sachs Reiterates Neutral Rating on Regenxbio Inc. (RGNX)
-
-
-
-
-
-
-
Raymond James Reiterates Outperform Rating on Regenxbio Inc. (RGNX)
-
-
-
-
-
-
-
Raymond James Defending Regenxbio Inc. (RGNX): 'we see this as a good entry point'
-
-
-
-
-
-
-
Regenxbio (RGNX) Announces FDA Acceptance and Priority Review of the BLA for RGX-121 for MPS II
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

